IL-22R alpha 1 Antibody [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # AF4294I
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
Janelia Fluor 549
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse IL-22 R alpha1
Thr18-Ala228
Accession # Q80XZ4
Thr18-Ala228
Accession # Q80XZ4
Specificity
Detects mouse IL‑22 R alpha1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 30% cross‑reactivity with recombinant human IL‑22 R is observed.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for IL-22R alpha 1 Antibody [Janelia Fluor® 549]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IL-22 R alpha 1
Long Name
Interleukin 22 Receptor
Alternate Names
CRF2-9, IL-22Ra1, IL-TIF-R1, IL22R alpha 1, IL22RA1
Gene Symbol
IL22RA1
Additional IL-22 R alpha 1 Products
Product Documents for IL-22R alpha 1 Antibody [Janelia Fluor® 549]
Product Specific Notices for IL-22R alpha 1 Antibody [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...